.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
UBS
McKesson
Mallinckrodt
Merck
Medtronic
Chinese Patent Office
QuintilesIMS
Federal Trade Commission
Julphar

Generated: November 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020006

« Back to Dashboard
NDA 020006 describes MANNITOL 5% IN PLASTIC CONTAINER, which is a drug marketed by Icu Medical Inc and B Braun and is included in two NDAs. It is available from two suppliers. Additional details are available on the MANNITOL 5% IN PLASTIC CONTAINER profile page.

The generic ingredient in MANNITOL 5% IN PLASTIC CONTAINER is mannitol. There are seventeen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the mannitol profile page.

Summary for 020006

Tradename:
4
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 020006

Mechanism of ActionOsmotic Activity
Physiological EffectIncreased Diuresis

Medical Subject Heading (MeSH) Categories for 020006

Suppliers and Packaging for NDA: 020006

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MANNITOL 10% IN PLASTIC CONTAINER
mannitol
INJECTABLE;INJECTION 020006 NDA B. Braun Medical Inc. 0264-7578 0264-7578-10 24 CONTAINER in 1 CASE (0264-7578-10) > 500 mL in 1 CONTAINER
MANNITOL 15% IN PLASTIC CONTAINER
mannitol
INJECTABLE;INJECTION 020006 NDA B. Braun Medical Inc. 0264-7578 0264-7578-10 24 CONTAINER in 1 CASE (0264-7578-10) > 500 mL in 1 CONTAINER

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength5GM/100ML
Approval Date:Jul 26, 1993TE:APRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength10GM/100ML
Approval Date:Jul 26, 1993TE:APRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength15GM/100ML
Approval Date:Jul 26, 1993TE:APRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Healthtrust
Harvard Business School
Moodys
US Army
Daiichi Sankyo
Citi
Express Scripts
Cerilliant
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot